PEQCX
Price
$34.01
Change
+$0.10 (+0.29%)
Updated
Dec 23 closing price
RMFCX
Price
$54.97
Change
+$0.24 (+0.44%)
Updated
Dec 23 closing price
Ad is loading...

PEQCX vs RMFCX

Header iconPEQCX vs RMFCX Comparison
Open Charts PEQCX vs RMFCXBanner chart's image
Putnam Large Cap Value C
Price$34.01
Change+$0.10 (+0.29%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.97
Change+$0.24 (+0.44%)
VolumeN/A
CapitalizationN/A
PEQCX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEQCX vs. RMFCX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEQCX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. PEQCX (33.6B). RMFCX pays higher dividends than PEQCX: RMFCX (1.69) vs PEQCX (0.62). PEQCX was incepted earlier than RMFCX: PEQCX (26 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. PEQCX (12.00). PEQCX has a lower initial minimum investment than RMFCX: PEQCX (0) vs RMFCX (250). PEQCX annual gain was more profitable for investors over the last year : 13.32 vs. RMFCX (11.11). RMFCX return over 5 years is better than : 37.80 vs. PEQCX (30.62).
PEQCXRMFCXPEQCX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years23 years-
Gain YTD12.1989.921123%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets33.6B102B33%
Annual Yield % from dividends0.621.6936%
Returns for 1 year13.3211.11120%
Returns for 3 years15.5312.38125%
Returns for 5 years30.6237.8081%
Returns for 10 years56.7859.3696%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA